biotech
- Home
- biotech
Public
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Alcidion secures major UK hospital network for Patientrack health monitoring
Smart healthcare continues to make strides in the United Kingdom with healthtech company Alcidion (ASX: ALC) to deploy their Patientrack monitoring system across the NHS Lanarkshire, the third largest health board in Scotland. With approximately 12,000 staff working across communities, health centres, clinics and three district hospitals, the 5-year agreement will see Alcidion roll out
Read MorePublic
Mayne Pharma strengthens oral contraceptives portfolio in lucrative U.S market
With the increasing competition amongst pharmaceutical companies being driven by a proliferation of generic brands, Mayne Pharma Group (ASX: MYX) has secured its position in the U.S as a leading oral contraceptives supplier by partnering with Novast Laboratories for 13 generic products. Of the 13 products, four have been approved by the U.S Food and
Read MorePublic
Alterity confirms FDA development pathway for Multiple System Atrophy treatment
After meeting with the FDA, biopharmaceuticals company Alterity Therapeutics (ASX: ATH) has confirmed Phase II clinical trial plans for their ATH434 compound in the treatment of Multiple System Atrophy (MSA), an incurable Parkinsonian disorder with no regulatory precedent. Due to the unique scenario where there are no accepted efficacy endpoints, guidance has been provided by
Read MorePublic
Eco-toxicity findings confirm Bio-Gene pesticide safe for aquatic life
Following preliminary eco-toxicity studies on limited aquatic species, agtech developer Bio-Gene Technology (ASX: BGT) has reported favourable results for its flagship next-gen insecticide, Flavocide. The studies were completed on guppy fish, water fleas and freshwater algae which represented key species of marine life most likely to be impacted by the introduction of pesticide. Following application
Read MorePublic
Osteopore continues winning streak with bone regeneration product approvals
3D printing medtech company Osteopore (ASX: OSX) is set to continue their successful streak, following news that the company has received Australian Therapeutics Goods Administration (TGA) approval for three craniofacial products, after being placed into a trading halt Friday afternoon. The Osteomesh, Osteoplug, and Osteoplug-C, are used primarily to fill voids in a patient’s bone,
Read MorePublic
TGA approves coronavirus testing kit, Genetic Signatures to flatten curve
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases in Australia after the Therapeutics Goods Association (TGA) approved their SARS-CoV-2 Detection Kit for sale in Australia. Regulatory approval in Australia follows authorisation which was granted in Europe 10 days ago with Genetic Signatures able
Read MorePublic
- 1
- 2